HempFusion Wellness Inc. Completes USD$17,000,000 Initial Public Offering and Commences Trading on the Toronto Stock Exchange Biotech Investing
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors Biotech Investing
HempFusion Wellness Inc. Shares Posted for Trading on the Toronto Stock Exchange on January 6, 2021 Under the Symbol CBD.U Biotech Investing
Risankizumab Phase 3 Results Demonstrate Improvements in Disease Activity Across Joint and Skin Symptoms Among Psoriatic Arthritis Patients Biotech Investing
Naturally Splendid Announces CANEX Foods, Latest Distributor of NATERA Plant Based Foods Biotech Investing
Bristol Myers Squibb to Present at J.P. Morgan's 39th Annual Virtual Healthcare Conference Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma Biotech Investing
